首页> 外国专利> Therapeutic agent for arteriosclerosis or arteriosclerotic disease, and diagnostic agent for arteriosclerosis or arteriosclerotic disease

Therapeutic agent for arteriosclerosis or arteriosclerotic disease, and diagnostic agent for arteriosclerosis or arteriosclerotic disease

机译:动脉硬化或动脉硬化疾病的治疗剂,以及动脉硬化或动脉硬化疾病的诊断剂

摘要

It is intended to ameliorate arteriosclerosis or arteriosclerotic disease through a pharmacological mechanism that reduces the size of the arteriosclerotic lesion. The agent of the present invention comprises a complex comprising an antibody binding to folate receptor beta (FRbeta) and a cytotoxin or a cytotoxic agent conjugated with the antibody, or the antibody as an active ingredient.
机译:其旨在通过减小动脉硬化病变的大小的药理机制来改善动脉硬化或动脉硬化疾病。本发明的药剂包括复合物,该复合物包括与叶酸受体β(FRbeta)结合的抗体和与该抗体缀合的细胞毒素或细胞毒性剂,或该抗体作为活性成分。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号